beraprost beraprost beraprost is a pharmaceutical drug used in several asian countries, including japan and south korea, as a vasodilator and antiplatelet agent. it is classified as a prostacyclin analog. beraprostclinical dataahfs/drugs.cominternational drug namesroutes ofadministrationoralatc codeb01ac19 (who) pharmacokinetic databioavailability50–70%metabolismunknownelimination half-life35–40 minutesidentifiers iupac name 4-butanoic acid cas number88430-50-6 y 88475-69-8pubchem cid6917951iuphar/bps1967chemspider5293169 yunii35e3njj4o6chebichebi:135633chemblchembl1207745 ncomptox dashboard (epa)dtxsid7049136 chemical and physical dataformulac24h30o5molar mass398.499 g·mol−13d model (jsmol)interactive image smiles cc#ccc(c)(/c=c/1(c21c3=cc=cc(=c3o2)cccc(=o)o)o)o inchi inchi=1s/c24h30o5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26h,6-7,9,11,14h2,1-2h3,(h,27,28)/b13-12+/t15?,17-,19+,20+,21-,23-/m0/s1 ykey:ctpohartnnsrsr-apjzlkagsa-n y ny (what is this?) (verify) it has been studied for the treatment of pulmonary hypertension and for use in avoiding reperfusion injury. clinical pharmacology as an analog of prostacyclin pgi2, beraprost affects vasodilation, which in turn lowers blood pressure. beraprost also inhibits platelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined. dosage and administration beraprost is administered orally as a pill available in strength of 20 mcg. dose ranges from 60 to 180 mcg in divided doses after meals.